Table 6.
Study | HD downgrading | Symptoms improvement | Persistence | Resolution | Recurrence | Reoperation (timepoint; type) | Follow-up (in months) | |
---|---|---|---|---|---|---|---|---|
Laser hemorrhoidoplasty | ||||||||
Karahaliloglu et al. 8 | - | - | - | - | 11.3%a |
54.7% (within 3 months, LH) |
12 | |
Jahanshahi et al. 11 | - | - | - | - | 0% | - | 12 | |
Brusciano et al. 12 | - | - | - | - | 0% | - | 8.6b | |
Plapler et al. 13 |
LH HC |
- | - | - |
60.4%c - |
- | - | 1 |
Naderan et al. 14 |
LH HC |
- | - | - |
70%a 76.7%a |
- |
0% 0% |
12 |
Alsisy et al. 15 |
LH HC |
- | - |
0%a 10%a |
100%a 90%a |
0% 0% |
0% 0% |
3 |
Poskus et al. 16 |
LH MP HC |
- | - | - |
72.5%a 58.5%a 82.5%a |
10%a 22%a 0%a, d |
- | 12 |
Hemorrhoidal laser procedure | ||||||||
Salfi et al. 9 | - | 91% | - | - | 9.4% | - | 12 | |
Giamundo et al. 17 | 77% | 91.7% | 7%a, c | - | 8.3%a | - | 5.8 (1–12)b | |
Crea et al. 18 | >85% | 85% | - | > 90%a | 5% | - | 15 (6–30)e | |
De Nardi et al. 19 | - | 86.3% | 9.8%a | 76.9%c | 7.8% |
7.8% (2 [1–5]b months; 2% RBL, 3.8% THD, 2% HC) |
26.3 ± 9.1b | |
Boarini et al. 20 | 80% | - | - | 83.6%a | - | - | 6 | |
Giamundo et al. 21 | - | - | 9.7%a, c, e | 90.3%a | - |
2.8% (6b months; 0.7% HeLP, 0.7% SH, 0.7% THD, 0.7% HC) |
12 | |
Giamundo et al. 22 |
HeLP RBL |
80% 40%d |
- | - |
90.0%a 53.3%a, d |
- | - | 6 |
HD hemorrhoidal disease, “-” not available, LH laser hemorrhoidoplasty, HC hemorrhoidectomy, MP mucopexy, RBL rubber band ligation, THD transanal hemorrhoidal dearterialization, HeLP hemorrhoidal laser procedure, SH stapled hemorrhoidopexy
aSymptomatic recurrence, resolution, or persistence
bExpressed as mean ± standard deviation or (range)
cProlapse recurrence, resolution, or persistence
dThe difference was statistically significant
eExpressed as median (range)
eDescribed as persistence in the results section, but as persistence or recurrence in the discussion section